Transthyretin as a thyroid hormone carrier: Function revisited

Clinical Chemistry and Laboratory Medicine

Volumn 40, Issue 12, 2002, Pages 1292-1300

  Palha, Joana Almeida ^a  

^a UNIVERSITY OF MINHO   (Portugal)

Author keywords

Cerebrospinal fluid; Choroid plexus; Thyoxine; Thyroid hormone; Transthyretin

Indexed keywords

ALBUMIN; CARRIER PROTEIN; HORMONE BINDING PROTEIN; LIOTHYRONINE; PLASMA PROTEIN; PREALBUMIN; THYROID HORMONE; THYROXINE; THYROXINE BINDING PROTEIN;

BRAIN TISSUE; CEREBROSPINAL FLUID; CHOROID PLEXUS; DEIODINATION; EUTHYROIDISM; HORMONE BINDING; HORMONE TRANSPORT; HUMAN; LIVER; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SECRETION; PROTEIN SYNTHESIS; REVIEW; THYROID FOLLICLE; THYROID HORMONE METABOLISM; THYROXINE METABOLISM; THYROXINE SYNTHESIS;

ANIMALS; BRAIN; CARRIER PROTEINS; HUMANS; PREALBUMIN; THYROID HORMONES;

MAMMALIA; RODENTIA;

EID: 0036910380     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2002.223     Document Type: Review

References (136)

1. Taurog A. Hormones synthesis: thyroid iodine metabolism. In: Braverman LE, Utiger RD, editors. The thyroid. Philadelphia: Lippincott Williams & Wilkins, 2000:61-85.
2. van Doorn J, Roelfsema F, van der Heide D. Conversion of thyroxine to 3,5,3′-triiodothyronine in several rat tissues in vivo: the effect of hypothyroidism. Acta Endocrinol (Kbn) 1986; 113:59-69.
3. Robbins J. Thyroid hormone transport proteins and the physiology of hormone binding: In: Braverman LE, Utiger RD, editors. The thyroid. Philadelphia: Lippincott Williams & Wilkins, 2000:105-20.
4. Benvenga S, Cahnmann HJ, Robbins J. Localization of the thyroxine binding sites in apolipoprotein B-100 of human low density lipoproteins. Endocrinology 1990; 127:2241-6.
5. Benvenga S, Cahnmann HJ, Rader D, Kindt M, Robbins J. Thyroxine binding to the apolipoproteins of high density lipoproteins HDL2 and HDL3. Endocrinology 1992; 131: 2805-11.
6. Benvenga S, Lapa D, Trimarchi F. Re-evaluation of the thyroxine binding to human plasma lipoproteins using three techniques. J Endocrinol Invest 2001; 24:RC16-8.
7. Sousa MM, Berglund L, Saraiva MJ. Transthyretin in high density lipoproteins: association with apolipoprotein A-I. J Lipid Res 2000; 41:58-65.
8. Benvenga S, Robbins J. Enhancement of thyroxine entry into low density lipoprotein (LDL) receptor-competent fibroblasts by LDL: an additional mode of entry of thyroxine into cells. Endocrinology 1990; 126:933-41.
9. Vranckx R, Rouaze M, Savu L, Nunez EA, Beaumont C, Link IL. The hepatic biosynthesis of rat thyroxine-binding globulin (TBG): demonstration, ontogenesis, and up-regulation in experimental hypothyroidism. Biochem Biophys Res Commun 1990; 167:317-22.
10. Vranckx R, Savu L, Maya M, Nunez EA. Characterization of a major development-regulated serum thyroxine-binding globulin in the euthyroid mouse. Biochem J 1990; 271: 373-9.
11. Stockigt JR. Serum thyrotropin and thyroid hormone measurement and assessment of thyroid hormone transport. In: Braverman LE, Utiger RD, editors. The thyroid. Philadelphia: Lippincott Williams & Wilkins, 2000:376-92.
12. Refetoff S, Robin NI, Fang VS. Parameters of thyroid function in serum of 16 selected vertebrate species: a study of PBI, serum T4, free T4 and the pattern of T4 and T3 binding to serum proteins. Endocrinology 1970; 86:793-805.
13. Refetoff S. Inherited thyroxine-binding globulin abnormalities in man. Endocr Rev 1989; 10:275-93.
14. Bartalena L. Recent achievements in studies on thyroid hormone-binding proteins. Endocr Rev 1990; 11:47-64.
15. Bartalena L. Studies on thyroxine-binding globulin. J Endocrinol Invest 1993; 16:353-71.
16. Sarne DH, Refetoff S. Normal cellular uptake of thyroxine from serum of patients with familial dysalbuminemic hyperthyroxinemia or elevated thyroxine-binding globulin. J Clin Endocrinol Metab 1988; 67:1166-70.
17. Refetoff S, Dwulet FE, Benson MD. Reduced affinity for thyroxine in two of three structural thyroxine-binding prealbumin variants associated with familial amyloidotic polyneuropathy. J Clin Endocrinol Metab 1986; 63:1432-7.
18. Rosen HN, Moses AC, Murrel JR, Liepnieks JJ, Benson MD. Thyroxine interactions with transthyretin: a comparison of 10 different naturally occurring human transthyretin variants. J Clin Endocrinol Metab 1993; 77:370-4.
19. Moses AC, Rosen HN, Moller DE, Tsukazi S, Hoddow JE, Lawlor J, et al. A point mutation in transthyretin increases affinity for thyroxine and produces euthyroid hyperthyroxinemia. J Clin Invest 1990; 86:2025-33.
20. Saraiva MJ. Transthyretin mutations in hyperthyroxinemia and amyloid diseases. Hum Mutat 2001; 17:493-503.
21. Savu L, Vranckx R, Rouaze-Romet M, Maya M, Nunez E, Treton J, et al. A senescence up-regulated protein: the rat thyroxine-dinding globulin (TBG). Biochim Biophys Acta 1991; 1097:19-22.
22. Rouaze-Romet M, Savu L, Vranckx R, Bleiberg-Daniel F, Le Moullac B, Gouache P, Nunez EA. Re-expression of thyroxine-binding globulin in post-weaning rats during protein and energy malnutrition. Acta Endocrinol (Kbn) 1992; 127:441-8.
23. Birch HE, Schreiber G. Transcriptional regulation of plasma protein synthesis during inflammation. J Biol Chem 1986; 261:8077-80.
24. Murakami T, Ohnishi S, Nishiguchi S, Maeda S, Araki S, Shimada K. Acute-phase response of mRNAs for serum amyloid P component, C-reactive protein and prealbumin (transthyretin) in mouse liver. Biochem Biophys Res Commun 1988; 155:554-60.
25. Wade S, Bleiberg-Daniel F, Le Moullac B. Rat transthyretin: effects of acute short-term food deprivation and refeeding on serum and cerebrospinal fluid concentration and on hepatic mRNA level. J Nutr 1988; 118:199-205.
26. Ingenbleek Y, Young V. Transthyretin (prealbumin) in health and disease: nutritional implications. Annu Rev Nutr 1994; 14:495-533.
27. Wenzel KW. Pharmacological interference with in vitro tests of thyroid function. Metabolism 1981; 30:717-32.
28. Ciszac E, Cody V, Luft JR. Crystal structure determination at 2.3-Å resolution of human transthyretin-3′,5′-dibromo-2′,4,4′,6-tetrahydroxyaurone complex. Proc Natl Acad Sci USA 1992; 89:6644-8.
29. Davis PJ, Spaulding SW, Gregerman RI. The three thyroxine-binding proteins in rat serum: binding capacities and effects of binding inhibitors. Endocrinology 1970; 87: 978-86.
30. Kabat EA, Moore DH, Landow H. An electrophoretic study of the protein components in cerebrospinal fluid and their relationship to the serum proteins. J Clin Invest 1942; 21:571-7.
31. Hagen GA, Solberg Jr LA. Brain and cerebrospinal fluid permeability to intravenous thyroid hormones. Endocrinology 1974; 95:1398-410.
32. Seibert FB, Nelson JW. Electrophoretic study of the blood protein response in tuberculosis. J Biol Chem 1942; 143:29-38.
33. Gavrilesco K, Courcon J, Hillion P, Uriel J, Lewin J, Grabar P. A study of normal human cerebrospinal fluid by the immunoelectrophoretic method. Nature 1955; 176:976.
34. Ingbar SH. Prealbumin: thyroxine binding protein of human plasma. Endocrinology 1958; 63:256-9.
35. Goodman DS. Retinoids and retinol-binding proteins. In: The Harvey Lectures 1987, Series 81:111-32.
36. Woeber KA, Ingbar SH. The contribution of thyroxine-binding prealbumin to the binding of thyroxine in human serum, as assessed by immunoadsorption. J Clin Invest 1968; 47:1710-21.
37. Goodman DS, Peters T, Robbins J, Schwick HG. Prealbumin becomes transthyretin? In: Nomenclature Committee of IUB-IUPAC Joint Comission on Biochemical Numenclature (JCBN). Newsletter J Biol Chem 1981; 256:12-4.
38. Kanda Y, Goodman DS, Canfield RE, Morgan FJ. The amino acid sequence of human plasma prealbumin. J Biol Chem 1974; 249:6796-805.
39. Mita S, Maeda S, Shimada K, Araki S. Cloning and sequence analysis of cDNA for human prealbumin. Biochem Biophys Res Commun 1984; 124:558-64.
40. Blake CCF, Geisow MJ, Oatley SJ, Rérat B, Rérat C. Structure of prealbumin: secondary, tertiary and quaternary interactions determined by Fourier refinement at 1.8 Å. J Mol Biol 1978; 121:339-56.
41. Andrea TA, Cavalieri RR, Goldfine ID, Jorgensen EC. Binding of thyroid hormones and analogues to the human plasma protein prealbumin. Biochemistry 1980; 19:55-63.
42. Cheng S-Y, Pages RA, Saroff HA, Edelhoch H, Robbins J. Analysis of thyroid hormone binding to human serum prealbumin by 8-anilinonaphtalene-1-sulfonate fluorescence. Biochemistry 1977; 16:3707-13.
43. Robbins J, Cheng S-Y, Gershengorn MC, Glinoer D, Cahnmann HJ, Edelhoch H. Thyroxine transport proteins of plasma: molecular properties and biosynthesis. Recent Progr Horm Res 1978; 34:477-519.
44. Savu L, Vranckx R, Maya M, Gripois D, Blouquit M-F, Nunez EA. Thyroxine-binding globulin and thyroxine-binding prealbumin in hypothyroid and hyperthyroid developing rats. Biochem Biophys Res Commun 1989; 992:379-84.
45. Vranckx R, Rouaze M, Savu L, Mechighel P, Maya M, Nunez EA. Regulation of rat thyroxine-binding globulin and transthyretin: studies in thyroidectomized and hypophysectomized rats given triiodothyronine or/and growth hormone. J Endocrinol 1994; 142:77-84.
46. Wakasugi S, Maeda S, Shimada K, Nakashima H, Migita S. Structural comparisons between mouse and human prealbumin. J Biochem 1985; 98:1707-14.
47. Tu GF, Cole T, Duan W, Schreiber G. The nucleotide sequence of transthyretin cDNA isolated from a sheep choroid plexus cDNA library. Nucleic Acids Res 1989; 17:6384.
48. Sundelin J, Melhus H, Das S, Eriksson U, Lind P, Trägår L, et al. The primary structure of rabbit and rat prealbumin and comparison with the tertiary structure of human prealbumin. J Biol Chem 1985; 260:6481-7.
49. Achen MG, Duan W, Pettersson TM, Harms PJ, Richardson SJ, Lawrence MC, et al. Transthyretin gene expression in choroid plexus first evolved in reptiles. Am J Physiol 1993; 265:R982-9.
50. Duan W, Achen MG, Richardson SJ, Lawrence MC, Wettenhall REH, Jaworowski A, et al. Isolation, characterization, cDNA cloning and gene expression of an avian transthyretin. Eur J Biochem 1991; 200:679-87.
51. Santos CR, Power DM. Identification of transthyretin in fish (Sparus aurata): cDNA cloning and characterisation. Endocrinology 1999; 140:2430-3.
52. Yamauchi K, Nakajima J, Hayashi H, Hara A. Purification and characterization of thyroid-hormone-binding protein from masu salmon serum. A homolog of higher-vertebrate transthyretin. Eur J Biochem 1999; 265:944-9.
53. Monaco HL, Rizzi M, Coda A. Structure of a complex of two plasma proteins: transthyretin and retinol-binding protein. Science 1995; 268:1039-41.
54. Raz A, Shiratori T, Goodman DS. Studies on the protein-protein and protein-ligand interactions involved in retinol transport in plasma. J Biol Chem 1970; 245:1903-12.
55. Heller J, Horwitz J. Conformational changes following interaction between retinol isomers and human retinol-binding protein and between the retinol-binding protein and prealbumin. J Biol Chem 1973; 248:6308-16.
56. Fex G, Albertsson PA, Hansson B. Interaction between prealbumin and retinol-binding protein studied by affinity chromatography, gel filtration and two-phase partition. Eur J Biochem 1979; 99:353-60.
57. Peterson PA. Studies on the interaction between prealbumin, retinol-binding protein and vitamin A. J Biol Chem 1971; 246:44-9.
58. Peterson PA. Characteristics of a vitamin A transporting protein complex occurring in human serum. J Biol Chem 1971; 246:7544-50.
59. Raz A, Goodman DS. The interaction of thyroxine with human plasma prealbumin and with prealbumin-retinol-binding protein complex. J Biol Chem 1969; 244:3230-7.
60. Herbert J, Wilcox JN, Pham K-TC, Freamau RT, Zeviani M, Dwoek A, et al. Transthyretin: a choroid plexus-specific transport protein in human brain. Neurology 1986; 36: 900-11.
61. Blay P, Nilsson C, Owman C, Aldred A, Schreiber G. Transthyretin expression in the rat brain: effect of thyroid hormone functional state and role in thyroxine transport. Brain Res 1993; 632:114-20.
62. Dickson PW, Aldred AR, Marley PD, Bannister D, Schreiber G. Rat choroid plexus specializes in the synthesis and secretion of transthyretin (prealbumin). Regulation of transthyretin synthesis in choroid plexus is independent from that in liver. J Biol Chem 1986; 261:3475-8.
63. Aldred AR, Brack CM, Schreiber G. The cerebral expression of plasma protein genes in different species. Comp Biochem Physiol 1995; 111B:1-15.
64. Schreiber G, Aldred AR, Jaworowski A, Nilsson C, Achen MG, Segal MB. Thyroxine transport from blood to brain via transthyretin synthesis in choroid plexus. Am J Physiol 1990; 258: R338-45.
65. Soprano DR, Soprano KJ, Goodman DS. Retinol-binding protein and transthyretin mRNA levels in visceral yolk sac and liver during fetal development. Proc Natl Acad Sci USA 1986; 83:7330-4.
66. Fung WP, Thomas T, Dickson PW, Aldred AR, Milland J, Dziadek M, et al. Structure and expression of the rat transthyretin (prealbumin) gene. J Biol Chem 1988; 263: 480-8.
67. Martone RL, Herbert J, Dwork AJ, Schon EA. Transthyretin is synthesized in the mammalian eye. Biochem Biophys Res Commun 1988; 151:905-11.
68. Ong DE, Davis JT, O'Day WT, Bok D. Synthesis and secretion of retinol-binding protein and transthyretin by cultured retinal pigment epithelium. Biochemistry 1994; 33:1835-42.
69. Jacobsson B, Collins VP, Grimelius L, Pettersson T, Sandstedt B, Carlström A. Transthyretin immunoreactivity in human and porcine liver, choroid plexus, and pancreatic islets. J Histochem Cytochem 1989; 37:31-7.
70. Soprano DR, Herbert J, Soprano KJ, Schon EA, Goodman DS. Demonstration of transthyretin mRNA in the brain and other extrahepatic tissues in the rat. J Biol Chem 1985; 260:11793-8.
71. Makover A, Moriwaki H, Ramakrishnan R, Saraiva MJM, Blaner WS, Goodman DS. Plasma transthyretin-tissue sites of degradation and turnover in the rat. J Biol Chem 1988; 263:8598-603.
72. Richardson SJ, Bradley AJ, Duan W, Wettenhall REH, Harms PJ, Babon JJ, et al. Evolution of marsupial and other vertebrate thyroxine-binding plasma proteins. Am J Physiol 1994; 266:R1359-70.
73. Harms PJ, Tu G-F, Richardson SJ, Aldred AR, Jaworowski A, Schreiber G. Transthyretin (prealbumin) gene expression in choroid plexus is strongly conserved during evolution of vertebrates. Comp Biochem Physiol 1991; 99B: 239-49.
74. Schreiber G, Pettersson TM, Southwell BR, Aldred AR, Harms PJ, Richardson SJ, Wettenhall REH, et al. Transthyretin gene expression evolved more recently in the liver than in the brain. Comp Biochem Physiol 1993; 105B:317-25.
75. Episkopou V, Maeda S, Nishiguchi S, Shimada K, Gaitanaris GA, Gottesman ME, et al. Disruption of the transthyretin gene results in mice with depressed levels of plasma retinol and thyroid hormone. Proc Natl Acad Sci USA 1993; 90:2375-9.
76. Hillier AP. The binding of thyroid hormones to phospholipid membranes. J Physiol 1970; 211:585-97.
77. Abe T, Kakyo M, Sakagami H, Tokui T, Nishio T, Tanemoto M, et al. Molecular characterization and tissue distribution of a new organic anion transporter subtype (oatp3) that transports thyroid hormones and taurocholate and comparison with oatp2. J Biol Chem 1998; 273:22395-401.
78. Abe T, Kakyo M, Tokui T, Nakagomi R, Nishio T, Nakai D, et al. Identification of a novel gene family encoding human liver-specific organic anion transporter LST-1. J Biol Chem 1999; 274:17159-63.
79. Friesema EC, Docter R, Moerings EP, Verrey F, Krenning EP, Hennemann G, et al. Thyroid hormone transport by the heterodimeric human system L amino acid transporter. Endocrinology 2001; 142:4339-48.
80. Pardridge WM. Transport of protein-bound hormones into tissues in vivo. Endocr Rev 1981; 2:103-23.
81. Pardridge WM. Plasma protein-mediated transport of steroid and thyroid hormones. Am J Physiol 1987; 252:E157-64.
82. Pardridge WM. Carrier-mediated transport of thyroid hormones through the rat blood-brain barrier: primary role of albumin-bound hormone. Endocrinology 1979; 105:605-12.
83. Pardridge WM, Mietus LJ, Frumar AM, Davidson BJ, Judd HL. Effects of human serum on transport of testosterone and estradiol into rat brain. Am J Physiol 1980; 239:E103-8.
84. Pardridge WM, Premachandra BN, Fierer G. Transport of thyroxine bound to human prealbumin into rat liver. Am J Physiol 1985; 248:G545-50.
85. Mendel CM. Modelling thyroxine transport to liver: rejection of the "enhanced dissociation" hypothesis as applied to thyroxine. Am J Physiol 1989; 257:E764-71.
86. Mendel CM. The free hormone hypothesis: a physiologically based mathematical model. Endocr Rev 1989; 10:232-74.
87. Mendel CM, Cavalieri RR, Gavin LA, Pettersson T, Inoue M. Thyroxine transport and distribution in Nagase analbuminemic rats. J Clin Invest 1989; 83:143-8.
88. Mendel CM, Weisiger RA, Jones AJ, Cavalieri RR. Thyroid hormones-binding proteins in plasma facilitate uniform distribution of thyroxine within the tissues: a perfused rat liver study. Endocrinology 1987; 120:1742-9.
89. Janssen OE, Golcher HM, Grasberger H, Saller B, Mann K, Refetoff S. Characterization of TW-binding globulin cleaved by human leukocyte elastase. J Clin Endocrinol Metab 2002; 87:1217-22.
90. Ekins RP, Sinha AK, Pickard MR, Evans IM, al Yatama F. Transport of thyroid hormones to target tissues. Acta Med Austriaca 1994; 21:26-34.
91. Divino CM, Schussler GC. Receptor-mediated uptake and internalization of transthyretin. J Biol Chem 1990; 265: 1425-9.
92. Divino CM, Schussler GC. Transthyretin receptors on human astrocytoma cells. J Clin Endocrinol Metab 1990; 71:1265-8.
93. Sousa MM, Saraiva MJ. Internalization of transthyretin. Evidence of a novel yet unidentified receptor-associated protein (RAP)-sensitive receptor. J Biol Chem 2001; 276:14420-5.
94. Kuchler-Bopp S, Dietrich JB, Zaepfel M, Delaunoy JP. Receptor-mediated endocytosis of transthyretin by ependymoma cells. Brain Res 2000; 870:185-94.
95. Sousa MM, Norden AG, Jacobsen C, Willnow TE, Christensen EI, Thakker RV, et al. Evidence for the role of megalin in renal uptake of transthyretin. J Biol Chem 2000; 275:38176-81.
96. Willnow TE, Hilpert J, Armstrong SA, Rohlmann A, Hammer RE, Burns DK, et al. Defective forebrain development in mice lacking gp330/megalin. Proc Natl Acad Sci USA 1996; 93:8460-4.
97. Mendel CM, Cavalieri RR, Weisiger RA. Uptake of thyroxine by the perfused rat liver: implications for the free hormone hypothesis. Am J Physiol 1988; 255:E110-9.
98. Mendel CM, Weisiger RA. Thyroxine uptake by perfused rat liver: no evidence for facilitation by five different thyroxine-binding proteins. J Clin Invest 1990; 86: 1840-7.
99. Mendel CM, Cavalieri RR, Kohrle J. Thyroxine (T4) transport and distribution in rats treated with EMD 21388, a synthetic flavonoid that displaces T4 from transthyretin. Endocrinology 1992; 130:1525-32.
100. Palha JA, Episkopou V, Maeda S, Shimada K, Gottesman ME, Saraiva MJ. Thyroid hormone metabolism in a transthyretin-null mouse strain. J Biol Chem 1994; 269: 33135-9.
101. Higueret P, Garcin H. Transport of thyroxine in serum of vitamin A-deficient rats. J Endocr 1979; 80:223-8.
102. Palha JA, Hays MT, Morreale de Escobar G, Episkopou V, Gottesman ME, Saraiva MJ. Transthyretin is not essential for thyroxine to reach the brain and other tissues in transthyretin-null mice. Am J Physiol 1997; 272:E485-93.
103. Palha JA, Fernandes R, Morreale de Escobar GM, Episkopou V, Gottesman M, Saraiva MJ. Transthyretin regulates thyroid hormone levels in the choroid plexus, but not in the brain parenchyma: study in a transthyretinnull mouse model. Endocrinology 2000; 141:3267-72.
104. Palha JA, Nissanov J, Fernandes R, Sousa JC, Bertrand L, Dratman MB, et al. Thyroid hormone distribution in the mouse brain: the role of transthyretin. Neuroscience 2002; 113:837-47.
105. Anderson GW. Thyroid hormones and the brain. Front Neuroendocrinol 2001; 22:1-17.
106. Oppenheimer JH, Schwartz HL. Molecular basis of thyroid hormone-dependent brain development. Endocr Rev 1997; 18:462-75.
107. Bernal J, Nunez J. Thyroid hormones and brain development. Eur J Endocrinol 1995; 133:390-8.
108. Burmeister LA, Pachucki J, St Germain DL. Thyroid hormones inhibit type 2 iodothyronine deiodinase in the rat cerebral cortex by both pre- and posttranslational mechanisms. Endocrinology 1997; 138:5231-7.
109. Dickson PW, Aldred AR, Menting JGT, Marley PD, Sawyer WH, Schreiber G. Thyroxine transport in choroid plexus. J Biol Chem 1987; 262:13907-15.
110. Southwell BR, Duan W, Alcorn D, Brack C, Richardson SJ, Köhrle J, et al. Thyroxine transport to the brain: role of protein synthesis by the choroid plexus. Endocrinology 1993; 133:2116-26.
111. Chanoine J-P, Alex S, Fang SL, Stone S, Leonard JL, Köhrle J, et al, Role of transthyretin in the transport of thyroxine from the blood to the choroid plexus, the cerebrospinal fluid, and the brain. Endocrinology 1992; 130:933-8.
112. Dratman MB, Crutchfield FL, Schoenhoff MB. Transport of iodothyronines from bloodstream to brain: contributions by blood:brain and choroid plexus:cerebrospinal fluid barriers. Brain Res 1991; 554:229-36.
113. Dratman MB, Crutchfield FL. Thyroxine, triiodothyronine, and reverse triiodothyronine processing in the cerebellum: autoradiographic studies in adult rats. Endocrinology 1989; 125:1723-33.
114. 125I]-Triiodothyronine in the rat brain: evidence for neuronal localization and axonal transport derived from thaw-mount film autoradiography. J Comp Neurol 1987; 60:392-408.
115. Palha JA, Saraiva MJ, Gottesman M. Decreased transthyretin (TTR) concentrations in the cerebrospinal fluid after lead exposure. Toxicol Appl Pharmacol 1997; 144:204.
116. Porterfield SP. Thyroidal dysfunction and environmental chemicals-potential impact on brain development. Environ Health Perspect 2000; 108(Suppl 3):433-8.
117. Brouwer A, van den Berg KJ. Binding of a metabolite of 3,4,3′,4′-tetrachlorobiphenyl to transthyretin reduces serum vitamin A transport by inhibiting the formation of the protein complex that carrying both retinol and thyroxine. Toxicol Appl Pharmacol 1986; 85:301-12.
118. Brouwer A. Inhibition of thyroid hormone transport in plasma of rats by polychlorinated biphenyls. Arch Toxicol Suppl 1989; 13:440-5.
119. de Vera N, Cristofol RM, Rodriguez Farre E. Protein binding and stability of norepinephrine in human blood plasma. Involvement of prealbumin, alpha 1-acid glycoprotein and albumin. Life Sci 1988; 43:1277-86.
120. Boomsma F, Man in't Veld AJ, Schalekamp MA. Not norepinephrine but its oxidation products bind specifically to plasma proteins. J Pharmacol Exp Ther 1991; 259:551-7.
121. Ernstrom U, Pettersson T, Jornvall H. A yellow component associated with human transthyretin has properties like a pterin derivative, 7,8-dihydropterin-6-carboxaldehyde. FEBS Lett 1995; 360:177-82.
122. Blake CCF, Oatley SJ. Protein-DNA and protein-hormone interactions in prealbumin: a model of the thyroid hormone nuclear receptor? Nature 1977; 268:115-20.
123. Borish L, King MS, Mascali JJ, Johnson S, Coll B, Rosenwasser LJ. Transthyretin is an inhibitor of monocyte and endothelial cell interleukin-1 production. Inflammation 1992; 16:471-84.
124. Burton PM, Iden S, Mitchell K, White A. Thymic hormone-like restoration by human prealbumin of azathioprine sensitivity of spleen cells from thymectomized mice. Proc Natl Acad Sci USA 1978; 75:823-7.
125. Burton PM, Hung P, Lin T, Lovelace C, White A. The effects of homogeneous human prealbumin on in vitro and in vivo immune responses in the mouse. Int J Immunopharmacol 1985; 7:473-81.
126. Burton PM, Horner BL, Jones GH, Lin T, Nestor Jr JJ, Newman SR, et al. Immuno-enhancing activity of the amino-terminal domain of human prealbumin: isolation, characterization and synthesis. Int J Immunopharmacol 1987; 9:297-305.
127. Dardenne M, Pleau J-M, Bach J-F. Evidence of the presence in normal serum of a carrier of the serum thymic factor (FTS). Eur J Immunol 1980; 10:83-6.
128. Jörnvall H, Carlström A, Pettersson T, Jacobsson B, Persson M, Mutt V. Structural homologies between prealbumin, gastrointestinal prohormones and other proteins. Nature 1981; 291:261-3.
129. Jian-Ren G, Hui-Qui J, Li-Ping H, Dai-Zong L, Xiao-Mei Z, Wei-Lie D, et al. Transthyretin (prealbumin) gene in human primary hepatic cancer. Sci China 1991; 34B:1312-8.
130. Saraiva MJ. Sporadic cases of hereditary systemic amyloidosis. N Engl J Med 2002; 346:1818-9.
131. Kohno K, Palha JA, Miyakawa K, Saraiva MJ, Ito S, Mabuchi T, et al, Analysis of amyloid deposition in a transgenic mouse model of homozygous familial amyloidotic polyneuropathy. Am J Pathol 1997; 150:1497-508.
132. Schwarzman AL, Gregorri L, Vitek MP, Lyubski S, Strittmatter WJ, Enghilde JJ, et al. Transthyretin sequesters amyloid β-protein and prevents amyloid formation. Proc Natl Acad Sci USA 1994; 91:8368-72.
133. Riisoen H. Reduced prealbumin (transthyretin) in CSF of severely demented patients with Alzheimer's disease. Acta Neurol Scand 1988; 78:455-9.
134. Palha JA, Moreira P, Wisniewski T, Frangione B, Saraiva MJ. Transthyretin gene in Alzheimer's disease patients. Neurosci Lett 1996; 204:212-4.
135. Lamb BT, Sisodia SS, Lawler AM, Slunt HH, Kitt CA, Kearns WG, et al. Introduction and expression of the 400 kilobase precursor amyloid protein gene in transgenic mice. Nature 1993; 5:22-8.
136. Sullivan GM, Hatterer JA, Herbert J, Chen X, Roose SP, Attia E, et al. Low levels of transthyretin in the CSF of depressed patients. Am J Psychiatry 1999; 156:710-5.